Activation of the ZBP1–cGAS–STING–Type I Interferon Axis as a Mechanistic Driver of Cardiomyopathy in Friedreich’s Ataxia
|Mar 13 2026
Investigating spinal sensory-motor circuit pathology in two mouse models of FA
|Apr 24 2025
Inhibition of the TLR4 receptor prevents neuro-inflammation and degeneration in frataxin-deficient sensory neurons
|Nov 17 2024
Design and synthesis of SynGR library to probe into the role of NSD-2,3 proteins in FXN expression in FRDA
|Nov 4 2024
Understanding the Pathogenesis of Friedreich’s Ataxia by Single-Cell Integration of Gene Expression, Epigenetics and Connectivity in the Cerebellar Nuclei
|Jul 23 2024
Characterization of FA iPSC-derived DRG organoid to decipher neurodevelopmental and neurodegenerative mechanisms
|Apr 1 2024
Dysregulated microglial Ca2+ homeostasis as a pathogenic contributor and therapeutic target in Friedreich’s ataxia
|Mar 1 2024
Developing and delivering of novel gene editing technologies to contract GAA repeats in Friedreich’s ataxia
|Nov 19 2023
Anatomical and functional analysis of corticospinal tract in FRDA mouse model
|Jul 19 2023
Investigating the Mechanosensory System in Friedreich’s Ataxia using Stem Cell Models
|Oct 19 2022
Illuminating how SynGRs liberate gene expression from heterochromatin
|Oct 19 2022
Engineering adeno-associated viral vectors to evade immune responses